Skip to main content

Earnings Aren’t Going to Be Pretty, but Buy F Stock Anyway

Earnings Aren’t Going to Be Pretty, but Buy F Stock AnywayWith earnings coming out next week, should you buy Ford (NYSE:F)? The automaker has seen its share of trouble from the novel coronavirus. With its auto plants sitting idle, expect them to continue burning through cash until we get back to "normal," which doesn't bode well for F stock.Source: Vitaliy Karimov / Shutterstock.com Based on numbers recently released by the company, cash burn could be over $5 billion per month. The automaker has built up a solid cash position to ride things out. But, let's just say 2020 isn't going to be a great year financially.So, why buy F stock? Especially now, just before earnings? Despite the plethora of bad news, shares today could be "priced for disaster."InvestorPlace - Stock Market News, Stock Advice & Trading TipsIn other words, shares may have been oversold relative to actual risks. Sure, shares could go lower in the near-term. But one to two years out, buying F stock today could be a shrewd move in hindsight. F Stock, The Pandemic, and EarningsFord reports earnings for the first quarter (Q1 2020) on April 28. But the company has already provided numbers. And they aren't pretty. The company expects a net loss of $2 billion for Q1 2020. * 7 of the Best Large-Cap Stocks to Buy Now Yet, investors already knew things were going to be rough for Ford this quarter. As a result, shares haven't fallen much further on this news.Since the preliminary earnings announcement on April 17, F stock has fallen from $5.17 per share to $4.77 per share. In other words, around a 7.7% drop. That pales in comparison to declines during the pandemic-driven sell-off.Ford shares started falling off a cliff in early February, cratering from around $9 per share to as low as around $4 per share, before slightly rebounding in wake of the $2 trillion stimulus package.We may have reached a bottom with F stock. Even if scary cash burn numbers make it look as if shares have a long ways to go before bottoming out.How bad is the cash burn? Let's run the numbers.The company's CFO says Ford has enough cash to last until the end of Q3 2020 (September 2020), assuming factories don't reopen. Based on a Bloomberg Intelligence credit analyst's calculations, the company has gone through $8 billion so far in 2020.But cash burn could be more severe as the shutdowns continue. Given the automaker had $30 billion left as of April 9, and the end of Q3 is 174 days after that date, the company is probably losing around $5.2 billion-$5.3 billion a month while plants sit idle. Darkest Before the DawnRe-opening an auto plant post-pandemic isn't going to be same as re-opening a restaurant or bar. Given the power the UAW (United Auto Workers) union holds over U.S. automobile production, they are yet another stakeholder who must sign off on resuming operations.Ford and its "Detroit Three" (legacy automaker) peers General Motors (NYSE:GM) and Fiat Chrysler (NYSE:FCAU) recently met with UAW representatives to discuss a restart timeline.No concrete restart date came out of it. As union officials remain fearful of the pandemic spreading on the factory floor, it's hard to tell really when auto plants can resume production.Yet, don't let this factor scare you off of F stock. I know what you're thinking, "$5 billion a month in cash burn?" Even if it's a short-term issue, the company could be carrying this additional debt for quite some time.And you would be correct. Ford is borrowing hand-over-fist to boost its cash position. Using borrowed money to cover losses, the company is going to be more levered than before.Yet, this may not a problem for those buying in at $5 per share and below. As mentioned above, shares have been oversold as bad news piles up. That means the potential upside in Ford's stock price if and when the auto industry rebounds outweighs the risk shares go to zero.Shares could dip further from here in the short-term. But, the risks of a Ford bankruptcy are less than you think. As Morgan Stanley analyst Adam Jonas discussed on CNBC in late March, the auto maker's efforts during the pandemic (manufacturing respirators, etc.) serve as a "good tactic against bankruptcy." With the Detroit Three doing their patriotic duty, it will be tough for Washington to refuse a bailout if government intervention winds up being their last lifeline. Consider F Stock at Today's PricesFord may be losing billions a month as their plants remain shut down. Yet, shares could be a buy at $5 per share or below. Given all of the bad news as of late, investors have oversold the automaker's shares, considering the remote chance of the stock heading to zero.Given the high risks involved, don't bet the ranch on F stock. But with shares close to the bottom, today's prices could be a solid entry point.Thomas Niel, contributor to InvestorPlace, has written single-stock analysis for web-based publications since 2016. As of this writing, Thomas Niel did not hold a position in any of the aforementioned securities. More From InvestorPlace * America's 1 Stock Picker Reveals Next 1,000% Winner * 25 Stocks You Should Sell Immediately * 1 Under-the-Radar 5G Stock to Buy Now * The 1 Stock All Retirees Must Own The post Earnings Aren't Going to Be Pretty, but Buy F Stock Anyway appeared first on InvestorPlace.




from Yahoo Finance https://ift.tt/2VDyWuw

Comments

Popular posts from this blog

Photo finish: Crashing sales force Olympus to sell iconic camera business

Sometimes, the vicissitudes of capitalism force companies to exit the businesses for which they’re best known. Olympus, once a leading light in the photography industry, is now joining that list. On Wednesday, the company said it planned to quit its 84-year-old camera business. The imaging giant, known for its once-pervasive digital cameras, agreed to sell off the declining unit by year’s end. Japan Industrial Partners, a private equity firm best known for buying Sony’s struggling Vaio computer line in 2014, agreed to purchase the business. Terms of the deal were not disclosed. A glance at Olympus’s financial statements provides all the rationale for the divestiture; as at rival manufacturers, camera sales have plummeted over the past decade. For the fiscal year ended March 31, Olympus’s camera unit declined 10% versus the year prior to  ¥43.6 billion, or $407 million. The unit’s sales have collapsed by three-quarters from a decade ago, when the company brought in ¥175 billion, or $

WHO says common steroids can slash death risk for the sickest coronavirus patients

Our mission to help you navigate the new normal is fueled by subscribers. To enjoy unlimited access to our journalism,  subscribe today . An old drug can learn new tricks during the coronavirus pandemic. That’s the main takeaway from the World Health Organization (WHO) in a new analysis of corticosteroids—a class of drugs which have existed for dozens of years and are far cheaper than new, experimental COVID treatments in development—suggesting that drugs like dexamethasone can slash the chances of COVID-19 related deaths by as much as 35% in the sickest patients. The WHO analysis of coronavirus drugs encompassed seven separate studies. And while an analysis of this sort—what’s called a “meta-analysis”—isn’t as rigorous as other types of trials like a randomized controlled study, the data are compelling. Corticosteroids have a very different action mechanism from many of the other coronavirus drugs in development. COVID-19 is a peculiar disease. Some who have been infected may be